Cardiff Oncology, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cardiff Oncology, Inc. (CRDF) on January 6, 2025, covering the event date of January 3, 2025. The Company is incorporated in Delaware and maintains its principal executive offices in San Diego, California.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report does not contain financial statements or performance metrics.
Material Changes
On January 3, 2025, the Board of Directors approved the Amended and Restated By-laws of the Company. This constitutes a corporate governance update rather than a financial or operational change.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, contingencies, or unusual items. The document is strictly procedural regarding the amendment of corporate bylaws.
Key Facts for Investors
- The Company's Board approved Amended and Restated By-laws on January 3, 2025.
- The full text of the Amended and Restated By-laws is filed as Exhibit 3.1 to this report.
- No financial data or operational updates are included in this specific filing.